Therapeutic drug monitoring (TDM) is to determine the drug exposure, pharmacological markers or efficacy indicators in patients, use quantitative pharmacological model, take the drug treatment window as the benchmark, and develop the individualized drug delivery scheme suitable for patients The core is individualized drug therapy

Neonatal genetic and metabolic disease screening refers to the population census, early detection and early treatment of some serious congenital and genetic diseases in the neonatal period, so as to avoid irreversible physical and intellectual development disorders This kind of disease often lacks specific symptoms in the neonatal period and even in the infant period Once the symptoms appear, irreversible damage has been formed, and the good opportunity for treatment has been lost However, bi

Mass spectrometry technology is widely used in chemistry, chemical industry, environment, energy, medicine, sports medicine, criminal science and technology, life science, material science and other fields However, the application in clinical diagnosis has just risen in recent years, and there are still some obstacles affecting its application Among them, laboratory construction is not standardized, sample processing process is complex, instrument operation is cumbersome, personnel quality req

It is the most common defect of the human sensory and acoustic nervous system caused by the genetic material of parents changed and passed on to the offspring Whether the parents are single or both deaf patients or healthy carriers, deafness genes will be passed on from parents to their children